vilanterol
别名 | GW642444X |
---|---|
Compound Class | Synthetic organic |
变动原因 | Vilanterol is an ultra-long-acting β2-adrenoreceptor agonist, belonging to a group of drugs termed ultra-LABAs. |
Related Product | 维兰特罗 |
Summary
是否批准为药物? | (FDA (2013)) |
---|---|
IUPAC Name | 4-[(1R)-2-[(6-{2-[(2,6-dichlorophenyl)methoxy]ethoxy}hexyl)amino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol |
别名 | GW642444X |
数据库链接
ChEMBL Ligand | CHEMBL1198857 |
---|---|
PubChem CID | 10184665 |
CAS Registry No. | 503068-34-6 |
Wikipedia | Vilanterol |
DrugCentral Ligand | 4799 |
GPCRdb Ligand | 7353 |
生物活性
生物活性评价 |
The sulfonamide class of antibacterial compounds are primarily bacteriostatic agents and have a broad spectrum of activity against both Gram-positive and Gram-negative species of bacteria (reviewed in |
---|---|
关联靶标 | β2-adrenoceptor |
临床资料
Summary of Clinical Use |
Vilanterol is contained in medications alongside a corticosteroid (eg |
---|---|
作用机制与药效学效应 | Vilanterol is a long-acting β2-adrenoceptor agonist. Upon inhalation, the drug activates airway β2-adrenoceptors which causes vasodilation of airway smooth muscle and eases breathing. The corticosteroid component of the combination drug activates the glucocorticoid receptor (GR), helping to reduce the release of pro-inflammatory chemicals in the damaged lung, thereby futher aiding breathing. |
结构
Canonical SMILES | OCc1cc(ccc1O)C(CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O |
---|---|
Isomeric SMILES | OCc1cc(ccc1O)[C@H](CNCCCCCCOCCOCc1c(Cl)cccc1Cl)O |
InChI | InChI=1S/C24H33Cl2NO5/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28/h5-9,14,24,27-30H,1-4,10-13,15-17H2/t24-/m0/s1 |
InChI key | DAFYYTQWSAWIGS-DEOSSOPVSA-N |